2-METHYL-2-(3-METHYL-4-NITRO-1H-PYRAZOL-1-YL)PROPANAMIDE, 95.0%, 100mg

1-(6-Aminonaphthalen-2-yl)ethanone, 95.0%, 1g

PEXMETINIB, 95%, 25mg

1,5-Diphenylcarbazide, min. 97%, pa, ACS, 10 g, plastic packaging.

2-(3-Chlorophenyl)ethyl cyclobutyl ketone, 97.0%, 1g

1-Trimethylsilyl-1H-Benzotriazole, 97.0%, 25g

2-Hydroxy-3-phenoxypropyl Acrylate (stabilized with MEHQ)>85.0%(GC)25g

(R)-3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine, 95.0%, 25g

5-AZASPIRO[2.3]HEXANE HCL, 95.0%, 500mg

Larotrectinib, 97%, 1g

1-(3,5-Di-O-p-chlorobenzoyl-2-deoxy-β-D-ribofuranosyl)-5-ethyluracil, 98%, 100mg

3-Fluoro-5-nitropyridin-2-ol, 95.0%, 25g

2,3-Difluoronitrobenzene, 98.0%, 10g